Cantor Fitzgerald began coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Free Report) in a report issued on Tuesday morning, Marketbeat Ratings reports. The firm issued an overweight rating and a $9.00 price objective on the stock.
Separately, Barclays initiated coverage on shares of Anteris Technologies Global in a research report on Tuesday. They set an “overweight” rating and a $22.00 price target for the company.
Check Out Our Latest Research Report on AVR
Anteris Technologies Global Stock Up 2.5 %
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
See Also
- Five stocks we like better than Anteris Technologies Global
- Buy P&G Now, Before It Sets A New All-Time High
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- How to Invest in the Best Canadian Stocks
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
